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 Alcoholic steatosis (AS) is the initial pathology associated with early stage 
alcoholic liver disease and is characterized by the accumulation of fat in the liver.  AS is 
considered clinically benign as it is reversible, as compared with alcoholic 
steatohepatitis (ASH) which is the next stage of alcoholic liver disease (ALD), and 
mostly irreversible.  Proteomics were used to investigate the molecular basis of AS to 
determine biomarkers representative of AS.  Liver tissue proteins at different stages of 
steatosis from a rodent model of AS were separated by two dimensional electrophoresis 
(2DE), followed by MALDI mass spectrometry (MS) identification of significantly 
expressed proteins.  Expression levels of several proteins related to alcohol induced 
oxidative stress, such as peroxiredoxin 6 (PRDX6) and aldehyde dehydrogenase 2 
(ALDH2) were reduced by 2 to 3-fold in ethanol fed rats, and suggested an increase in 
oxidative stress.  Several proteins involved in fatty acid and amino acid metabolism were 
found at increased expression levels, suggesting higher energy demand upon chronic 
exposure to ethanol.  In order to delineate between the effects of fat accumulation and 
oxidative stress, an in vitro hepatocyte cell culture model of steatosis was developed.  
HepG2 cells loaded with oleic acid surprisingly demonstrated lower cytotoxicity upon 
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oxidative challenge (based on lactate dehydrogenase activity) and inflammation (based 
on TNF-α induced activation of the pro-inflammatory transcription factor NF-κB).  We 
also examined the effect of oleic acid loading in HepG2 cells on protein carbonylation, 
which is an important irreversible protein modification during oxidative stress that leads 
to protein dysfunction and disease.  Fat-loaded hepatocytes exposed to oxidative stress 
with tert-butyl hydroperoxide (TBHP) contained 17% less carbonylated proteins than the 
non-fat loaded control.  Mass spectrometric analysis of carbonylated proteins indicated 
that known classical markers of protein carbonylation (e.g., cytoskeletal proteins, 
chaperones) are not carbonylated in oleic acid loaded HepG2 cells, and suggests that the 
protective effect of fat loading is through interference with protein carbonylation.  While 
counterintuitive to the general concept that AS increases oxidative stress, our fat loading 
results suggests that low levels of fat may activate antioxidant pathways and ameliorate 
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1.  INTRODUCTION 
 The overall goal of this study is to elucidate the molecular basis of alcoholic 
steatosis (AS).   Chronic ingestion of alcohol leads to a sequence of hepatic pathologies 
associated with alcoholic liver disease (ALD),  ranging from alcoholic steatosis (AS) to 
cirrhosis and liver failure (1-3).  Steatosis or the accumulation of fat in the liver is the 
initial pathology that is common to all aspects of ALD.  AS is generally considered 
clinically benign as it is reversible (i.e., fat accumulation can be reversed). On the other 
hand, the subsequent stages of ALD such as alcoholic steatohepatitis (ASH) and are 
mostly irreversible (2) .  The progression of ALD to ASH represents a rate limiting step 
in the progression of ALD, because approximately 50% of individuals with ASH go onto 
develop end-stage liver diseases such as cirrhosis (2-4).  
Although AS reverts upon alcohol withdrawal (5), research indicates that the 
accumulation of fat leads to subsequent liver complications, with the severity of damage 
being related to the extent of fat accumulation (6-8).  Liver damage can have serious 
repercussions as steatotic livers are also highly vulnerable to infection, inflammation, or 
oxidative stress (9-11).  Since, diagnosis and intervention at the AS stage has a higher 
likelihood of returning a patient to normal hepatic function, it is important to understand 
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However, since the accumulation of fat itself can lead to some degree of 
oxidative stress, the interaction between these two factors is likely to be important in AS 
and early stage ALD. Therefore, investigating the effects of fat accumulation and 
oxidative stress, both individually and in combination, can lead to greater mechanistic 
understanding of AS and approaches for attenuating complications arising from AS. 
One of the main difficulties associated with ameliorating fat accumulation in the 
liver is the lack of reliable diagnostic markers. Researchers have proposed carbohydrate 
dependent transferrin, which is known to be lower in alcoholics (12), and ethanol 
glucuronide (a direct ethanol metabolite) (13) as markers for early stage ALD.  But 
neither of these accurately indicates the progression of AS or ASH.  Proteomic studies 
have had great success in identifying prognostic and diagnostic markers for several 
diseases, including alcohol-related diseases, cerebral palsy, severe combined 
immunodeficiency, and Alzheimer’s disease (14-17).  Recently, two dimensional 
electrophoresis (2DE) based protein separation and quantification followed by MALDI-
TOF MS-identification has been used to identify differentially expressed proteins from 
brains of alcohol preferring and alcohol non-preferring rats (18).  This study and others 
indicate that a 2DE proteomics study has the potential in identifying early stage ALD 
markers.  However, to-date no liver-enriched proteins have been identified from alcohol-
treated liver.    
We hypothesize that a comprehensive proteomic analysis of steatotic livers can 
lead to a fundamental understanding of AS as well as the identification of diagnostic 
markers for AS. Using an in vivo rodent model for AS and a two dimensional gel 
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electrophoresis (2DE) / matrix assisted laser desorption identification (MALDI) mass 
spectrometry (MS) proteomics, we systematically investigated the protein basis 
underlying AS.  In parallel, we used an in vitro hepatocyte culture system to investigate 
the effects of fat accumulation and oxidative stress independently.  Since oxidative stress 
also leads to irreversible modification of proteins (e.g., carbonylation) and cellular 
dysfunction (19-22), we also used proteomic methods to establish the extent of protein 
carbonylation and identify proteins that are carbonylated under conditions of oxidative 
stress and steatosis.   
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2.  BACKGROUND  
2.1  Alcoholic Liver Disease 
Alcohol abuse is a leading cause of health problems in the developed world. (23).  
In the United States, alcoholism costs more than $185 billion and results in about 
100,000 deaths per year (17).  The liver is the most common target for alcohol and 
chronic alcohol consumption leads to the development of alcoholic liver disease (ALD).  
While, the pathogenesis of ALD has been extensively studied (2, 6, 24-27), far less is 
known about the mechanisms underlying for the development and progression of ALD.  
A complex relationship exists between the amount of alcohol consumption and the 
likelihood of developing ALD (8), and there is considerable individual variability in the 
development of alcohol related liver injury.  The first major pathological condition in the 
progression of ALD is alcoholic steatosis (fatty liver).  Alcoholic steatosis (AS) 
progresses gradually to alcoholic steatohepatitis (fatty liver combined with 
inflammation), then to fibrosis, and ultimately cirrhosis (2). AS is thought to occur 
rapidly upon alcohol consumption, but there is much less clarity on further progression 
of ALD.  Furthermore, evidence exists that alcohol alone may not be enough to cause 
steatohepatitis and necrosis, and additional factors may be needed for the development 
of disease (2, 27).  
2.2  Alcoholic Steatosis and Alcoholic Steatohepatitis 
Steatosis is the first and most common pathology in ALD and occurs in up to 
90% of alcoholics.  Fatty liver is thought to be mainly a result of metabolic disturbances, 
such as decreased fatty acid oxidation, increased triglyceride synthesis, reduced fat 
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export, and mobilization of extrahepatic fat stores (28-31).  The metabolism of ethanol to 
acetaldehyde, and its subsequent conversion to acetate produces NADH.  The cellular 
accumulation of NADH increases substrate available for fatty acid synthesis, as well as 
disrupts mitochondrial beta oxidation, thereby leading to fat accumulation (32).  
Steatosis has long been considered a benign condition, as even severe cases of AS 
recovered after 3-4 weeks of alcohol withdrawal (5, 33, 34).    However, more recent 
studies indicate that the metabolic changes taking place during the steatosis may also 
sensitize the cells to further injury (9, 12, 35, 36).  Lieber (29) suggested that metabolic 
changes of fatty liver alone may be insufficient to cause inflammation.  It is now 
believed that degree of fat accumulation in the liver correlates to the susceptibility of 
subsequent liver damage (6).  Researchers have shown that fatty liver is highly 
vulnerable to oxidative stress or injury mediated by endotoxins or cytokines (9-11).  
While these studies show vulnerabilities of steatotic livers, one study also showed that a 
fatty liver induced by 5 weeks of ethanol exposure demonstrated enhanced capacity to 
regenerate and consequent decline in hepatic injury (37).  This was not due to reduced 
CYP2E1 activity, but possibly through activation of the transcription factor NF-κB (37).  
Evidence exists that alcohol alone may not be enough to cause steatohepatitis and 
necrosis, and further studies are needed to understand mechanisms of AS, and identify 
biomarkers leading to subsequent pathological stages of ALD (1).  While, a detailed 
understanding of the mechanisms underlying the transition from AS to ASH is lacking, it 
is known continued consumption of alcohol in humans eventually results in neutrophilic 
steatohepatitis (38, 39).  Neutrophil infiltration into the liver is hallmark of ASH and 
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contributes to the pathology of ALD.  Alcoholic steatohepatitis reverts back to normal 
hepatic histopathology approximately only 10% of the time (40).  Most patients with 
steatohepatitis (almost 50%) go on to develop fibrosis and cirrhosis (Figure 1).  
Steatohepatitis, therefore represents a major rate limiting step in the progression towards 
cirrhosis and clinical liver disease (2, 3).  It would be beneficial to patients with ALD to 






Figure 1.  Progression of alcoholic liver disease.  Consumption of ethanol 
produces hepatic pathology in sequence, ranging from steatosis (fatty liver) on 
one extreme, to fibrosis/cirrhosis on the opposite end of the spectrum (1). 
2.3  Alcohol Metabolism and Oxidative Stress 
The generation of reactive oxygen species (ROS) is an unavoidable consequence 
of aerobic respiration.  Superoxide ( 2
⋅ −Ο ) is a major ROS generated from electron 
transport processes (e.g. ATP synthase I, and cytochrome p450), as well as various 
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oxidase enzymes.  Evidence for the role of 2
⋅ −Ο  in ALD comes from the studies 
demonstrating an inverse relationship between superoxide dismutase (SOD) and liver 
injury (41).  SOD is an enzyme that reduces 2
⋅ −Ο  to hydrogen peroxide (H2O2).  Kessava 
et al. (42) showed that SOD1 knockout mice develop more severe liver damage after 
treatment with ethanol.  While 2
⋅ −Ο  is not a potent oxidant, it reacts catalytically with 
enzyme metal centers to produce more potent oxidants such as hydroxyl radical (OH˙) 
(43), hypochlorous acid (HOCl) (44), and peroxynitrite (ONOO-) (45).  Under basal 
conditions cells have adequate antioxidant systems to deal with the ROS generated 
during normal cellular processes, however consumption of alcohol is thought to cause 
metabolic changes that leads to increased oxidative stress, such that the generation of 
ROS begins to overwhelm cellular antioxidant systems.   
Three main mechanisms explain the effects of alcohol on oxidative stress (1).  
The direct metabolite of alcohol is acetaldehyde, which is a very reactive compound.  
The accumulation of acetaldehyde is thought to be primarily responsible for symptoms 
of alcohol ingestion, as it has been shown to form adducts with biomolecules such as 
lipids (16).  Metabolism of ethanol and acetaldehyde also reduces NAD+ to NADH, and 
the shifting of this NADH/NAD+ ratio greatly reduces NAD+ available for carbohydrate 
and lipid metabolism.  This decrease in metabolic rate reduces the available cellular ATP 
pool (46) and limits energy available to antioxidant pathways; thereby, indirectly leading 
to greater accumulation of ROS.  In addition, ethanol also activates the CYP2E1 
pathway for the metabolism of ethanol, which leads to increased ROS generation (47). 
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2.4  Effects of Oxidative Stress 
Oxidative attack on proteins by ROS can lead to reversible or irreversible 
changes. The ROS associated with oxidative stress causes cellular damage by attacking 
several cellular components such as lipids and proteins. Hydroxyl radicals can damage 
lipids through a process called lipid peroxidation (48).  Malondialdehyde is an end 
product of lipid peroxidation that has been used as a biomarker for oxidative stress (48).  
Proteins are also commonly subject to modification by ROS. While some of these 
changes are considered harmless, others may lead to inactivation of the protein.  
Irreversible proteins modifications tend to inactivate proteins and lead to permanent 
cellular damage (49).  Reversible modifications such as s-glutathionylation, s-
nitrosation, and methionine sulfoxidation may not be entirely unintentional and may 
serve dual purposes.  These modifications may serve to protect proteins by blocking 
sensitive residues from irreversible oxidation and also modulate protein function (redox 
regulation and signaling) (49-51).     
Protein carbonylation is the largest class of irreversible protein modification.  
Carbonylation is characterized as the non-enzymatic irreversible modification of proteins 
by a variety of oxidative pathways that results in the addition of carbonyl group.  Protein 
carbonylation occurs mainly by direct oxidation of the side chains of lysine, arginine, 
proline, and threonine.   
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Figure 2.  Covalent addition of lipid peroxidation product, 4-HNE.  This is a 
major source of protein carbonylation. 
 
 
Covalent addition of lipid peroxidation products such as 4-hydroxy-2-nonenal (HNE) 
(13) to lysine, histidine, and cystine or n-terminal residues is also a major source of 
carbonylation, as shown in Figure 2.  Protein carbonylation is especially damaging since 
cells are unable to repair them and leads to either removal of the modified protein via the 
ubiquitin/proteasomal system or aggregation.  There are many examples relating 
carbonylation to protein dysfunction.  In the mitochondria of Drosophila melanogaster, 
the activity of enzymes such as acotinase and adenine nucleotide translocase was found 
to be inhibited with an increase in carbonylation (52-54).  Carbonylation was also found 
to interfere with chaperone function and protein folding (55, 56).  There is much 
evidence that oxidative stress is involved in many disease states, such as aging (57), and 
the irreversible nature of protein carbonylation makes it an attractive target of study. 
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3.  MATERIALS AND METHODS  
3.1  Reagents and Supplies 
Two dimensional electrophoresis (2DE) gel strips were purchased from (Bio-Rad 
Laboratories, Hercules, CA).  All reagents and supplies for two dimensional gel 
electrophoresis (2DE) buffers, cell lysis buffers, and SDS-PAGE were purchased from 
Fisher Scientific (Hampton, NH), unless otherwise noted.  Deoxyribonuclease (DNase), 
ribonuclease (RNase), iodoacetamide, and oleic acid were purchased from MP 
Biomedical (Solon, Ohio).  Cell culture media and reagents were purchased from 
Hyclone, (Logan, UT), unless otherwise noted.   
3.2  Animals 
Rat livers used in this study were provided by the laboratory of Dr. S. Ramaiah 
(Dept. of Veterinary Pathobiology, Texas A&M University, College Station TX).  
Procedures followed for rats were as follows.  Male Sprague-Dawley rats (220-250 g) 
were purchased from Harlan Sprague Dawley, (Houston, TX).  Male Sprague-Dawley 
rats were housed individually in cages in a temperature-controlled animal facility with a 
12-h light-dark cycle. Rats were utilized after a 1-week equilibration period.  Rats were 
divided into two groups (n=20 each), control diet group and experimental diet group.  
Rats in the experimental group were further divided into a group fed for 3 weeks and a 
group fed for 6 weeks.  The experimental groups were then placed on a Lieber DeCarli 
AS diet model  (37, 58, 59).  The rats were fed either control (isocaloric control diet 
where the calories were adjusted with maltose-dextrin) or EtOH-containing (35.5% of 
total calories) Lieber-DeCarli diet (Bio-Serv, Frenchtown, NJ) for a period of six weeks 
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for the control and three or six weeks for the EtOH groups, respectively.  For the first 
day, rats received plain liquid diet; next, alcohol-treated rats received liquid diet 
containing alcohol to 2% and 4% (w/v), each for 2 days. The 4% alcohol diet was then 
continued for six weeks. The energy distribution from the EtOH liquid is as follows; 
18% protein, 35% fat and either 47% carbohydrate (control group) or 11.5% 
carbohydrate (maltose dextrin) and 35.5% EtOH (EtOH fed groups). The food 
consumption was recorded daily and the control rats were pair-fed according to the food 
consumption of EtOH-fed rats. Rats were weighed at the beginning of the study and 
weekly thereafter. Calories consumed by each rat were measured daily. Rats were 
sacrificed at the end of 3 and 6 weeks respectively (n=10) by CO2 asphyxiation. An 
additional control group (n=10 each, 4% chow) was also employed.  No significant 
difference in body weight gain was observed between isocaloric controls and EtOH fed 
rats.  Livers were harvested from the animals and perfused with phosphate buffered 
saline (PBS) before being frozen at -80 ˚C until needed.   
3.3  Cell Culture   
HepG2 cells (ATTC, Manassas, VA) were cultured in media containing 9.6 g/l 
modified eagle medium/Earle’s balanced salt solution (MEM/EBSS) powdered media, 
1.62 g/l sodium bicarbonate, 110 mg/l sodium-pyruvate, 10% fetal bovine serum, 200 
units/ml penicillin, and 200 µg /ml streptomycin.  Cells were maintained at 37 ˚C under 
a humidified 5% CO2 environment.  H35 rat hepatoma cells with a NF-κB reporter 
plasmid (H35 NF-κB) (60) were cultured in Dulbecco’s minimal eagle’s medium 
supplemented with 10% bovine serum, 200 units/ml penicillin, and 200 µg /ml 
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streptomycin. This cell line was generated by stably inserting a DNA fragment 
consisting of four tandem repeats of the NF-κB DNA binding sequence upstream of the 
CMV-minimal promoter and a 2h half-life variant of the enhanced green fluorescence 
protein (d2EGFP) (60). 
3.4  Two Dimensional Electrophoresis   
Liver tissue samples were homogenized in a standard two dimensional 
electrophoresis (2DE) buffer consisting of 2M thiourea, 7M urea, 4 wt% CHAPS, 50 
mM DTT, 0.5 vol% ampholytes (pH 3-11) (Bio-Rad Laboratories, Hercules, CA).  One 
tablet of Complete Mini™  protease inhibitor cocktail (Roche, Basel, Switzerland) was 
added to 10 ml buffer.  Nuclease stock solution was prepared that contained 100 mM 
Tris pH 7, 50 mM MgCl, RNase 0.5 mg/ml, and DNase 1.0 mg/ml.  After 
homogenizing, nuclease stock was added 1:10 to the 2DE buffer.   The homogenate was 
centrifuge at 13000 rcf for 15 min, after which the supernatant was collected and the 
protein concentration determined by the BCA assay (Bio-Rad).  The sample was further 
processed using the 2DE ReadyPrep (Bio-Rad) clean up kit per the manufacturer’s 
instructions.  
Homogenized supernatants were diluted in a buffer containing 9.5 M urea, 2 wt% 
CHAPS, 18 mM DTT, and  0.5 % ampholytes.  Two sizes of immobilized pH gradient 
(IPG) strips (pH 5-8) (Bio-Rad) were used during the experiment.  All spot detection and 
image analysis were done using 7cm strips, while 13.5 cm strips were used for gels for 
excising spots for MS analysis.  40 µg of protein was loaded onto 7 cm strips and 300 µg 
was loading onto 13.5 cm strips.  After a minimum of 16 hrs of rehydration, isoelectric 
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focusing (IEF) was carried out on a Protean IEF cell (Bio-Rad) in 3 steps: 250V for 15 
minutes, followed by a linear gradient of 250V – 4000V for one hour, and then 4000V 
for 5 hours.  Proteins in the IPG strips were then reduced with DTT and alkylated with 
iodoacetamide in SDS equilibration buffer for fifteen minutes each as previously 
described (55).  SDS-PAGE was conducted on 10% acrylamide gels at 125V for 70 
minutes.  Seven cm gels were fixed for 15 minutes in solution containing 20% methanol 
and 7% acetic acid and stained with Sypro Ruby stain (Invitrogen, Carlsbad, CA) 
overnight.  The 13.5 cm gels were stained with GelCode Coomassie stain (Pierce, 
Rockford, IL).  Gels were imaged using a VersaDoc 3000 imager (Bio-Rad), and image 
analysis was conducted using PDQuest 7.4 software (Bio-Rad).  After imaging and 
analysis, statistically significant differentially expressed protein spots were selected for 
excision.   Spots were manually excised from the 13.5 cm gel with a 1 ml pipette, 
subjected to in-gel digestion using sequencing grade trypsin (Promega, Madison, WI), as 
previously described (61), and then used for MALDI-TOF-MS analysis. 
3.5  MALDI Mass Spectrometry   
Trypsin-digested protein spots were spotted onto MALDI targets using a 
ProMS™ robot capable of sample cleanup prior to MALDI-MS analysis (Genomic 
Solutions, Ann Arbor, MI).  The MALDI-MS experiments were performed in a 4700 
Proteomics Analyzer MALDI-TOF/TOF (Applied Biosystem, Foster City, CA).  Twenty 
tandem MS spectra per spot were acquired.  All MS and MS/MS data were queried 
against the Swiss-Prot protein sequence database using the GPS Explorer (Applied 
Biosystems) software.  The parameters for database searching were as follows: 
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taxonomy, Rattus Norvegicus; database, Swiss Prot; enzyme, trypsin; maximum missed 
cleavages, 1; variable modifications, oxidation (Met); peptide tolerance, 85 ppm; and 
MS/MS fragment tolerance, 0.3 Da. The generated MALDI-MS data was confirmed by 
re-analyzing five spots.   
3.6  In vitro Fat Loading Model 
Fat loading of HepG2 cells was done by exposing cells at ~ 70% confluency to 
1.0 mM oleic acid for 48 hr.  An oleic acid stock solution (75 mM) was prepared by 
mixing oleic acid with a solution of 3 mg/ml solution of bovine serum albumin and 75 
mM sodium hydroxide, with vortexing and heating to aid in dissolution of oleic acid. 
The solution was sterilized by passing through a 0.22 micron syringe filter.  The stock 
solution dissolved into culture media at desired final media concentrations. 
The extent of fat loading was assessed by oil red O staining.  An oil red O (Alfa 
Aesar, Ward Hill, MA) stock solution was made by dissolving 0.7 g oil red O in 200 ml 
isopropanol and passing mixture through a 0.22 µm syringe filter.  Oil red O working 
solution was prepared by combining four parts deionized water with six parts oil red O 
stock solution and passing through a syringe filter.  Cultured cells were fixed with 10% 
formalin in phosphate buffered saline for 2 h, with the buffer being replaced with fresh 
formalin containing buffer after the first 10 minutes.  After the formalin solution was 
removed, cells were rinsed with 60% isopropanol and allowed to dry.  The oil red O 
working solution was added to cells and incubated for 10 minutes.  The cells were rinsed 
with water to remove excess stain, dried briefly, and then imaged. 
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3.7  Oxidative Challenge Experiments with Tert-Butyl Hydroperoxide   
Oxidative challenge experiments were conducted on fat-loaded and non fat-
loaded HepG2 cells at approximately 85%-90% confluency.   Standard media was 
repaced with low serum media containing 1% fetal bovine serum.  Tert-butyl 
hydroperoxide (TBHP) (Acros Organics, Geel, Belgium) was added to the media at the 
desired final concentrations.  After an 8 hr exposure, culture supernatants were removed, 
and stored at -20 °C.  The culture flasks were rinsed with PBS and frozen at -80 ˚C until 
further processing.   
3.8  LDH Cytoxicity Assay   
Lactate dehydrogenase (LDH) levels in supernatants from fat-loaded and TBHP 
exposed HepG2 cells were measured using the Cytotox-One LDH cytoxicity assay 
(Promega, Madison, WI).  Equal volumes (100 µl)  of culture supernatant and cytoxicity 
assay buffer were combined and incubated according to the manufacturer’s instructions.  
LDH measurements were made in replicate for each cell exposure condition. 
3.9  NF-κB Reporter Assays and Fluorescence Microscopy  
H35 NF-κB cells were grown in 6 well plates (Corning, NY) and loaded with 
0.15 or 0.90 mM oleic acid as described above for HepG2 cells.  Reporter cells were 
exposed to 25 ng/ml TNF-α (R&D Systems, Minneapolis, MN) for 24 hrs in triplicate.  
GFP measurements were made using an Axiovert 200M fluorescence microscope (Zeiss, 
Thornwood, NY). Cell culture dishes were placed in a controlled environment chamber 
in the microscope and maintained at 37 ˚C and 10% CO2 throughout the experiment. 
Multiple imaging locations (3 per culture well) were randomly selected and the positions 
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marked before the addition of TNF-α using the 'mark and find' feature of the using the 
Zeiss AxioVision imaging software. Fluorescence and phase contrast images were 
obtained at the marked positions throughout the duration of the experiment using a 20X 
objective every 1 h for 24 h using an AxioCam MrM digital camera. 
3.10  Biotin Tagging of Carbonylated Proteins 
Carbonylated proteins from whole cell extracts were linked to biotin hydrazide 
following the protocol described by Mirzaei et al. (20, 21).  HepG2 cells (~5x106 cells) 
were lysed with 600 µl of lysis buffer (0.1 % w/v SDS, 0.5 % w/v sodium deoxycholate, 
1.0 % w/v CHAPS, 0.1 M NaCl, 0.1 M sodium phosphate, 1 mM EDTA; pH 7.5), 
supplemented with 80 µl nuclease stock solution (100 mM sodium bicarbonate pH 7, 50 
mM MgCl, RNase 0.5 mg/ml, and DNase 1.0 mg/ml), 10 µl of mammalian protease 
inhibitor cocktail (Sigma Aldich, St. Louis, MO), and 70 µl of 50 mM biotin hydrazide 
(Pierce, Rockwell, IN) stock solution in DMSO.  Half of this lysis solution was added to 
the cells, and incubated for 15 minutes, and the lysate collected.  This step was repeated 
with the remaining lysis solution.  The lysate was incubated for 30 minutes with 15 µM 
sodium cyanoborohydride (Fisher Scientific, Hampton, NH) to reduce hydrazone bonds. 
The lysate was incubated for at least 30 minutes, passed through a 22 gauge needle ten 
times, and centrifuged at 13000 rcf for 8 mins at 4 ˚C.  The supernatant was collected 
and dialyzed to remove detergents and excess reagents.   Dialysis cassettes (2.0K 
MWCO, 0.5-2.0 ml) were purchased from Pierce and hydrated for 2 minutes in dialysis 
buffer containing 25 mM ammonium bicarbonate (pH 8.0) and 4 mg/ml BSA.  Cell 
lysates were added to the cassettes per manufacturer’s instructions, and the lysates were 
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dialyzed for two hours after which the buffer was replaced with fresh dialysis buffer.  
The buffer was replaced again after two hours, and then dialyzed for at least eight hours.  
The concentration of carbonylated protein in the dialyzed lysate was assayed by the 
Bradford assay (Bio-Rad).   
3.11  Affinity Purification of Carbonylated Proteins   
One ml of monomeric avidin beads (Pierce, Rockford, IL) was placed in a 5 ml 
centrifuge column (Pierce).  In order to bind non-reversible sites, the column was 
washed by adding 3 ml of elution buffer containing 2 µM biotin and 25 mM ammonium 
bicarbonate, vortexing the beads, centrifuging at 1000 rcf for 45 seconds. The washing 
step was repeated twice, and the column regenerated by washing three times with 3 ml 
of regeneration buffer containing 0.1 M glycine, pH 2.8.   The column was then washed 
four times with 3 ml of 25 mM ammonium bicarbonate.  The dialyzed sample was added 
to the column and incubated at room temperature for one hour with gentle vortexing 
every 20 minutes and then centrifuged.  The column was then washed 4 times with 3 ml 
of 25 mM ammonium bicarbonate to remove nonspecifically bound proteins.  The 
biotinylated carbonylated proteins were eluted of the column by washing the beads five 
times with 0.7 ml of the elution buffer.  The flow-through was collected and then 
lyophilized, using a Centrivap concentrator and cold trap (Labconco, Kansas City, MO). 
 
 18
3.12  Carbonylated Protein Detection and LC/MS/MS Sample Preparation   
Lyophillized carbonylated proteins were rehydrated either in 50 µl of 25 mM 
ammonium bicarbonate for quantification using the Bradford assay or in 40 µl of 
reducing SDS-PAGE buffer (62) and resolved on a 7 cm 10% acrylamide gel.  Gels were 
fixed for 15 minutes in solution containing 20% methanol and 7% acetic acid and 
stained with Sypro Ruby stain overnight.  Stained gels were imaged using a VersaDoc 
imager (Bio-Rad) and gel lanes were manually excised and cut into 36 gel slices.  The 
gel slices were used for robotic in gel digestion and mass spectrometry analysis.   
3.13  LC MS/MS Analysis  
Peptides from each gel slice were separated using reverse phase chromatography 
on a 150 µm X 10cm column (Vydac) using an LC-Packings autosampler and pumps 
(LC Packings, Sunnyvale, CA).  A gradient of 2-40% acetonitrile was used to elute the 
peptides from the column at a flow rate of 1 µL/min.  MALDI matrix (5mg/mL α-cyano-
4-hydroxycinnamic acid) was mixed with the column eluant through a “T” junction at 
1.4 µl/min and spotted directly onto a MALDI sample plate using an LC-Packings 
Probot.  All MALDI-MS experiments were performed using a 4800 Proteomics 
Analyzer (Applied Biosystems). Data were acquired with the reflectron detector in 
positive mode (700-4500 Da, 1900 Da focus mass) using 800 laser shots (40 shots per 
sub-spectrum) with internal calibration. Collision induced dissociation tandem MS 
spectra were acquired using air at the medium pressure setting as the collision gas with 1 
kV of collision energy. All MS and MS/MS data were searched against the Swiss-Prot 
protein sequence database using the GPS Explorer (Applied Biosystems) software.
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                                                        4.  RESULTS 
4.1  Two Dimensional Gel Electrophoresis   
Two Dimensional Electrophoresis (2DE) was used to investigate changes in the 
rat liver proteome during alcoholic steatosis generated using the Lieber-DiCarli model. 
Liver proteins were extracted from animals in a six weeks ethanol fed group, a three 
weeks ethanol fed group, and a control group, and separated by 2DE as described in 
Materials & Methods. In order to account for biological variability, liver tissue from 
three animals was included in each experimental group, and each tissue sample was 
processed in duplicate (for a total of 6 gels per experimental group).  Based on 
preliminary optimization results (not shown), first dimension isoelectric focusing (IEF) 
strips were loaded with 40 µg of protein. Second dimension gels were stained with a 
fluorescent stain (Sypro Ruby) because of its sensitivity and broad dynamic range.  
Under these separation conditions, a total of 175 spots were detected on all gels.  
Representative gel images from each experimental group are shown in Figures 3A – C. 
A composite master gel was generated using the PDQuest image analysis software (Bio-
Rad) in which protein spot features present in all the gels were imported onto a single 
synthetic gel (Figure 3D).   
 The intensity of each protein spot (i.e., spot volume) was normalized to the spot 
volume of the entire gel (i.e., of all the protein spots).  Statistically significant changes in 
protein expression were determined using two sequential data analysis criteria. First, a 
protein spot had to be present in a minimum of 4 out of 6 gels for each sample to be 
included in the analysis. Next, protein spots were analyzed based on the fold-change in 
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expression. A protein spot in a gel from the ethanol-treated group was determined to 
exhibit a statistically significant change in expression if its spot volume was 1.3-fold 
different (increased or decreased) relative to the control group.  The 1.3 fold change 
(plus/minus) value was the lowest fold-change that was different from the untreated 
control by one standard deviation (i.e. 67% confidence limits). This analysis resulted in 
21 spots (corresponding to 18 proteins) being classified as differentially expressed in 













































































































































Figure 3.  Representative 2DE gel images from steatotic livers.  A. isocaloric 
control group, B. 3 weeks ethanol fed group, C. 6 weeks ethanol fed group, D. 
composite master gel image.  
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Proteins determined as differentially expressed were identified using MALDI-
TOF mass spectrometry.  In order to facilitate excision of protein spots, a 13 cm IEF 
strip was loaded with 350 µg of protein. Second dimension was performed using 11 cm 
Criterion precast gels (BioRad) and stained with Gelcode Blue stain for visualization. 
Protein spots were manually excised by comparing to the 7 cm gel images, digested with 
trypsin, purified, and analyzed using mass spectrometry.  All of the excised proteins 
spots resulted in a positive identification, with most protein scores over one hundred.   
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Figure 4.  Composite master gel image with annotated up or down regulated 
proteins. 
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The identified differentially expressed proteins are shown in Table 1.  Figure 4 is a 
composite master gel image with annotated up or down regulated proteins.  The proteins 
can be identified from their SSP numbers, which are listed in Table 1. 
Two trends are evident in the proteome data. First, a majority of differentially 
expressed proteins were mitochondrial proteins involved in amino acid and fat 
metabolism, chaperone proteins.  This is not surprising, as the mitochondria are well 
established as an important site for oxidative damage; therefore, any treatment that 
generates ‘stress’ is expected to be reflected in the mitochondrial proteome. Second, 
proteins differentially expressed at 6 weeks were also significantly altered at 3 weeks as 
well, indicating that alterations in protein expression seen with steatosis are initiated at 
an early stage during ethanol exposure.  
The up-regulation of proteins involved in fat and amino acid metabolism was 
observed. Acyl-CoA dehydrogenase and delta3,5-delta2, 4-dienoyl-CoA isomerase are 
both involved in mitochondrial beta oxidation of fatty acids (63, 64), with the former 
enzyme catalyzing the first step in the process. Similarly, 3-hydroxyisobutyrate 
dehydrogenase is an oxidoreductase that acts on CH-OH group of donors and is involved 
in leucine, isoleucine, and valine catabolism (65), while 2-oxoisovalerate dehydrogenase 
is an oxidoreductase that acts on aldehyde or oxo-group of donors (65).  ADP/ATP 
translocase 2 is increased in expression, which catalyzes the exchange of ADP and ATP 
across the mitochondrial membrane. 
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 Table 1.  Differentially expressed proteins in normal and steatotic livers.  


















Senescence marker protein-30 (SMP-
30) (Regucalcin) Q03336 588 1201 -1.85 -1.71 
Myosin Va (Myosin 5A) (Dilute 
myosin heavy chain, non-muscle) Q9QYF3 50 1202 -2.51 -2.25 
Phosphatidylethanolamine-binding 
protein (PEBP) P31044 531 2001 -1.53 -2.01 
Hsc70-interacting protein (Hip) 
(Putative tumor suppressor ST13) P50503 87 2403 -1.21* -1.92 
Isocitrate dehydrogenase [NADP] (cp) P41562 786 8401 -2.04 -1.89 
Ketohexokinase (EC 2.7.1.3) (Hepatic 
fructokinase) Q02974 364 5101 -1.53 -1.56 
Endoplasmic reticulum protein ERp29 
precursor (ERp31) P52555 643 5102 -1.57 -1.80 
Plectin 1 (PLTN) (PCN) P30427 62 4202 -1.99 -1.65 
Adenosine kinase (AK) Q64640 238 4401 -1.77 -1.28* 
Peroxiredoxin 6 ((Antioxidant protein 
2) O35244 856 3004 -1.33 -1.62 
3-hydroxyanthranilate 3,4-
dioxygenase(3-HAO) P46953 729 2101 -1.61 -1.50 
Aldehyde dehydrogenase (ALDH 2)  P11884 218 3502 -2.36 -1.97 
Aldehyde dehydrogenase (ALDH 2)  P11884 713 4503 -1.49 -1.70 
Serum albumin precursor P02770 581 3803 1.70 1.90 
Plectin 1 (PLTN) (PCN) P30427 51 6103 10.99 11.93 
3-hydroxyisobutyrate dehydrogenase, 
(HIBADH) (mp) P29266 356 6101 1.64 1.33 
ADP/ATP translocase 2 Q09073 58 6501 3.49 3.43 
Acyl-CoA dehydrogenase, short-chain 
specific, (SCAD) (mp) P15651 551 7306 1.47 2.30 
Acyl-CoA dehydrogenase, short-chain 
specific, (SCAD) (mp) P15651 102 6301 9.29 13.58 
Delta3,5-delta2,4-dienoyl-CoA 
isomerase, (mp) Q62651 147 7101 1.69 2.07 
2-oxoisovalerate dehydrogenase (mp) P11960 645 4402 3.48 2.77 
Glutamate dehydrogenase, (GDH) 
(mp) P10860 488 7602 1.73 1.67 
 
Note: marked entries were lower then 1.3 fold change cut-off. 
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Interestingly, both aldehyde dehydrogenase (ALDH2) and peroxiredoxin 6 
(PRDX6) were found to be down-regulated in the ethanol group as compared to the 
control. In the liver, ethanol is first converted to acetaldehyde, which is thought to be 
more toxic than ethanol itself (47). ALDH2 is the enzyme responsible for metabolizing 
acetaldehyde to acetic acid; therefore, its down-regulation suggests an accumulation of 
acetaldehyde and increasing hepatotoxicity.  PRDX6 is an important antioxidant enzyme 
that is involved in cellular redox regulation (66). Specifically, PRDX6 reduces H2O2 and 
phospholipid hydroperoxides and is an important mediator in the protection against 
oxidative injury. The decrease in PRDX6 expression is indicative of increased oxidative 
stress in the liver after 3 and 6 weeks of ethanol consumption.  
While one would expect an increase in the expression of anti-oxidant systems 
during oxidative stress, prior reports have shown that a decrease in anti-oxidant enzymes 
itself is an indicator of oxidative stress. This is because reactive oxygen species (ROS) 
are constantly generated in the cell during metabolism and are scavenged by anti-oxidant 
systems. This equilibrium is disturbed when there is an increase in the production of 
ROS, which leads to oxidative stress. This, in turn, leads to down-regulation of anti-
oxidant systems, and further increases ROS levels and oxidative stress. Therefore, the 
down-regulation of PRDX6 is indicative of hepatocellular damage and increased ROS 
levels in the ethanol-treated group. 
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4.2  In vitro HepG2 Fat Loading Model 
Our data, combined with previous work implicating fat accumulation and 
oxidative stress with ALD (6-8), motivated the development of an in vitro experimental 
model that would allow independent investigation of the effects fat loading and 
oxidative stress in hepatocytes.  A fat loading hepatocyte cell culture model was 
developed with oleic acid as the model fatty acid because it has been reported to have 
the least toxicity to cells (67, 68).   
A fat loading solution (sodium oleate) was developed as described in Materials & 
Methods to produce a solution that dissolved easily in media and did not significantly 
alter media pH.  Oil red O staining was used to verify that hepatocytes were loaded with 
fat, as shown in Figure 5. The data show significant lipid accumulation after 48 h 
exposure with no obvious loss of viability, and indicates this model can be used for 
generating steatotic hepatocytes. 
 
Control 0.90 mM Oleic 0.15 mM Oleic 
Figure 5.  Fat accumulation in oil red O stained HepG2 cells.  Cells were exposed to 
indicated oleic acid concentration for 48 hours. 
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  In order to simulate the effect oxidative stress during AS, fat loaded hepatocytes 
were initially exposed to a direct oxidant such as hydrogen peroxide.  However, it is 
likely that H2O2 is rapidly scavenged by hepatocytes which possess extensive catalase 
and peroxidase enzymes (69), and much higher concentrations may be required to 
generate oxidative stress.  Therefore, we used TBHP as the pro-oxidant molecule instead 
of H2O2.  Since TBHP is not a substrate of catalase, it allows for greater generation of 
hydroxyl radicals (69).  Since, oxidant exposure times beyond 6-8 hrs begin to show 
signs of apoptosis in many cells (69).  Therefore, an exposure time of 8 hr with 500 µm 
TBHP was chosen for subsequent experiments.   
4.3  Cytotoxicity in Fat-loaded HepG2 Cells 
The LDH assay is a standard method of measuring the cytotoxicity of many 
chemicals.  Fat- loaded and non fat-loaded HepG2 cells were either exposed to TBHP or 
to blank buffer.  Reduced serum media (1% vs. 10%) was used to conduct the exposure 
experiment, as prior reports (69) have suggested that serum components may quench the 
applied oxidative stress.  Figure 6 shows that fat-loaded cells have lower levels of LDH 
in the culture supernatant, both in the presence and absence of TBHP. Since LDH is a 
marker for cell membrane integrity, these results suggest that oleic acid-loaded HepG2 
cells are less susceptible to pro-oxidant damage as compared to normal cells.  These 
results are somewhat surprising, as several studies have suggested that fat accumulation 






























































Figure 6.  LDH activity in HepG2 culture supernatants exposed to 0.15 mM oleic 




4.4  Cytokine Inflammation in Fat-loaded HepG2 Cells   
It has been proposed that during AS, hepatocytes become sensitized to the effects 
of cytokines (9-11), which leads to steatohepatitis  (i.e., a 2-hit model).  Therefore, we 
investigated the extent of inflammation in fat-loaded hepatocytes reporter cells by 
monitoring the activation of the transcription factor NF-κB by the cytokine TNF-α. This 
is a relevant model as TNF- α is well established to be present during steatohepatitis and 
NF-κB is a known pro-inflammatory transcription factor. Experiments were carried out 
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using rat hepatoma (H35) GFP-reporter cells for NF-κB (60). Reporter cells were loaded 
with 0.15 or 0.90 mM oleic acid for 48 h and exposed to 10 ng/mL of TNFα.  Activation 
of NF-κB leads to expression of GFP from the minimal CMV promoter and 
fluorescence, which was continuously monitored using fluorescence microscopy. The 
data in Figure 7 show that the 0.15 and 0.90 mM oleic acid treated cells displayed 
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Figure 7.  H35 reporter cells expressing NF-κB linked GFP.  H35 cells were fat 
loaded with oleic acid for 48 hr and the exposed to 25 nM TNFα for 24 hours.  
Fluorescence intensity was measured every hour. 
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suggesting that TNF-α−mediated NF-κB activation is attenuated in the fat loaded cells.  
This result is consistent with the LDH cytotoxicity assay results showing that fat-loaded 
cells are less susceptible to oxidative stress. 
4.5  Isolation and Identification of Carbonylated Proteins  
Carbonylated proteins from TBHP-treated fat-loaded or control HepG2 cells 
were tagged with biotin hydrazide and affinity purified using monomeric avidin-linked 
beads as described in Materials & Methods.  The lysis buffer for this procedure 
contained components that were all dialyzable and did not contain amines (e.g. Tris) that 
could compete with the biotin hydrazide for Schiff base formation. The protocol used 
was adapted from Mirzai et al (20), with the main difference being that procedure was 
conducted in semi-batch mode using disposable centrifuge spin columns.  Equal 
amounts of protein from TBHP-treated control or fat-loaded HepG2 cells were loaded 
onto each column, bound to the monomeric avidin in the column, and eluted as 
described in M&M. Quantification of the eluted (carbonylation) protein showed that 
cells treated with 0.15 mM oleic acid prior to TBHP exposure had 17% less carbonylated 
protein than normal cells exposed to TBHP, and indicated that carbonylated protein 
levels were decreased in the oleic acid-loaded samples upon TBHP exposure as 
compared to normal cells.  However, this measurement of carbonylated protein content 
does not provide any information on the extent of carbonylation of specific proteins. 
Therefore, mass spectrometry was used to identify carbonylated proteins in normal and 
fat-loaded HepG2 cells exposed to TBHP. 
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Parallel samples from TBHP-treated fat-loaded or control cells were purified and 
separated on 8-16% SDS PAGE using standard protocols and visualized using Sypro 
Red staining. Qualitative inspection of the gel image (Figure 8), as well as quantification 
of the overall protein in the gel (not shown) by densitometry was consistent with the 
Bradford assay results (i.e. less protein was present in TBHP-exposed fat-loaded cells 
compared to normal controls). Each lane in the gel was cut into 36 evenly spaced slices 
of 1-2 mm. Proteins in each gel slice were digested in-gel with trypsin, and subjected to 
LC-MS/MS analysis.  The mass spectrometry data show that 249 carbonylated proteins 
were identified from the non fat loaded TBHP treated cells, while only 119 proteins were 
identified from TBHP-treated fat loaded cells.  Only 24 proteins were common between 
the two samples (Figure 9).  Since carbonylated proteins are typically cleared from cells 
through the proteasomal/ubiquitin system or aggregate in the cell, leading to cellular 
dysfunction, a decrease in carbonylation is an indicator of increased resistance to 
oxidative stress.  The overall trend of finding fewer carbonylated proteins in the fat 
loaded sample is consistent with the data from the Bradford assay and the gel density 
measurement showing less carbonyl content with fat loading. 
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N  Non Fat-Loaded Sample 





Figure 8.  Carbonylated proteins resolved on an 8-16% acrylamide gel.  Gel 
lane containing non fat-loaded (N) sample showed average density of 17% less 
than the fat loaded sample (F). 
 Non Fat-loaded + TBHP Fat-loaded + TBHP 




Figure 9.  Distribution of carbonylated proteins in normal and fat-loaded HepG2 cells.   
Selected proteins belonging to different functional categories (e.g., metabolism) 
that were carbonylated in either of the experimental groups are listed in Table 2.  
Cytoskeletal proteins were identified in both experimental groups; this is expected as 









































  Table  2.  Carbonylated proteins detected in normal and fat-loaded HepG2 cellsExperimental Group in which 
Protein Detected  




Non Fat Loaded 
+ TBHP  
Fat Loaded +   
TBHP 
etabolism Proteins       
ructose-bisphosphate aldolase A P05062 - + 
otassium-transporting ATPase alpha 
hain 2 P54707 + - 
alate dehydrogenase (mp) P40926 + - 
lyceraldehyde-3-phosphate 
ehydrogenase P04406 + - 
at Transport and Synthesis Proteins       
ong chain acyl coA ligase P33121 + - 
TP-binding cassette sub-family A 
ember 1 O95477 + - 
-acylglycerol O-acyltransferase 1 Q96PD6 + - 
ong-chain fatty acid transport protein 6 Q9Y2P4 - + 
ytoskeletal Proteins       
ollagen Q01955 + - 
atenin P26232 + - 
yosin V P35580 + + 
ctin, cytoplasmic 2 P63261  + + 
ntioxidant Proteins       
hioredoxin reductase 1 Q16881 - + 
haperone Proteins       
eptidyl-prolyl cis-trans isomerase P68106 + - 
SP10 P61604 + - 
SP75 Q12931 + - 
naJ homolog P59910 + - 
rotein disulfide-isomerase precursor P07237 + - 
eat shock 70 kDa protein 4 P34932 - + 
eat-shock protein 105 kDa Q92598 - + 
bitiquin & Drug Resistance Protein       
biquitin carboxyl-terminal hydrolase 
4 Q70CQ2 + - 
3 ubiquitin-protein ligase UBR1 Q8IWV7 + - 
robable E3 ubiquitin-protein ligase 
YCBP2 O75592 + - 
ultidrug resistance-associated protein 
 Q5T3U5 + - 
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It is interesting to note that long-chain fatty acid binding protein 6 was carbonylated only 
in the oleic acid treated sample.  It is unclear whether this protein exhibits greater than 
average susceptibility to carbonylation or if simply greater quantities were induced by 
the fat-loading.   
Chaperone proteins are common targets of ROS attack and researchers have 
identified damaged or malfunctioning chaperone proteins as part cellular pathologies 
(71).  Peptidyl-prolyl cis-trans isomerase is an abundant and ubiquitous folding protein 
that catalyzes the cis-trans isomerization of certain proline residues (72).  The fact that 
these proteins are carbonylated in normal HepG2 cells but not in oleic-loaded cells 
further supports the hypothesis that oleic acid-loading protects HepG2 cells against 
TBHP-induced oxidative stress. 
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5.  DISCUSSION, SUMMARY, AND CONCLUSIONS 
Alcoholic liver disease is a significant public health problem and costs associated 
with alcoholism are approximately $185 billion annually (23).  The major pathologies of 
ALD are alcoholic steaotosis, alcoholic steatohepatitis, and upon continued ethanol 
consumption, fibrosis and cirrhosis.  Steatosis represents an attractive target for 
understanding the molecular basis of ALD not only because there is a lack of 
understanding of molecular mechanisms underlying this disease, but also of its 
subsequent progression to ASH and end-stage liver disease.  From a clinical stand point, 
targeting AS for diagnosis and treatment is desirable, because once ALD progresses to 
ASH, only 10% of livers revert back to normal (40). 
 Our 2DE-MS analysis identified 18 proteins as differentially expressed between 
the ethanol and control groups (Table 1).  Interestingly, these 18 spots were detected in 
both the 3 weeks and 6 weeks ethanol fed groups. The observation that proteins 
characterizing steatosis at 3 weeks are also differentially expressed at 6 weeks suggests 
changes in protein expression occur rapidly during the development of AS.  The modest 
changes in expression between the 3 weeks group and the 6 weeks ethanol fed group 
also suggests that effect of ethanol on protein expression levels off after 3 weeks; 
however, prior reports (1) have shown that extensive pathological changes are observed 
only after 6 weeks of alcohol exposure. Together, our data are consistent with the notion 
that alcohol consumption rapidly induces steatosis (1, 2).  
Alcohol consumption up-regulated the expression of proteins involved in fat and 
amino acid metabolism, and likely reflects increased cellular demand for energy in AS.  
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One possible source for increased energy requirements is the response to alcohol-
induced oxidative stress.  Increased ATP requirement would be expected during 
oxidative stress, as several studies (73, 74) have linked ATP depletion with oxidative 
stress and related cellular damage.  Acyl-CoA dehydrogenase and delta3,5-delta2, 4-
dienoyl-CoA isomerase are both involved in mitochondrial beta oxidation of fatty acids 
(63, 64).   The former catalyzes the first step of beta oxidation, and the latter is necessary 
for the beta oxidation of unsaturated fatty acids, namely docosahexaenoic acid (64).  It is 
interesting that these enzymes are upregulated, as the depletion of NAD+ from ethanol 
and acetaldehyde metabolism is thought to interfere with fatty acid metabolism (75).  3-
hydroxyisobutyrate dehydrogenase is necessary for branched chain amino acid 
catabolism (65) and its increase also suggests an increased energy requirement.  
The increase in ADP/ATP translocase 2 (involved in the movement of ATP and ADP 
across the mitochondrial membrane) also supports the AS induced increase in cellular 
energy production.  It would interesting to verify increased fatty acid beta oxidation and 
ATP generation during AS.   
 The expression levels of ALDH2 and PRDX6 are reduced in the ethanol treated 
group compared to the control group.  While one might expect that a state of oxidative 
stress induces an increase in the expression of anti-oxidant systems, several studies have 
actually reported that key enzymes involved in counteracting the effects of oxidative 
stress are actually reduced during oxidative stress, and thus their reduced expression 
actually indicates a state of oxidative stress.  A recent study (76) also showed that 
mitochondrial proteins (e.g. ALDH2) of alcohol-fed rats were oxidatively modified and 
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nitrosylated, and that the enzymatic function of these proteins was reduced.  It has been 
suggested that the cysteine residues and metal centers found at the active sites of many 
anti-oxidant and metabolism proteins makes them more vulnerable to ROS attack (76, 
77). The expression levels of such oxidatively-modified proteins are often decreased, as 
has been demonstrated for glutathione S-transferase A4 (GSTA4) in obese mice (78).  
Therefore, it is possible most of the decrease in PRDX6 and ALDH2 is due to increased 
carbonylation.  Together, these changes in protein expression clearly indicate an 
increased state of oxidative stress in AS. 
 Our data showing an increase in enzymes involved fatty acid oxidation (acyl-
CoA dehydrogenase and delta3,5-delta2, 4-dienoyl-CoA isomerase) is contrary to the 
generally accepted view that AS results in decreased fatty acid oxidation.  This 
motivated the development of an in vitro experimental model that would allow the 
investigation of the effects of fat accumulation and oxidative stress separately.   A fat 
loading hepatocyte cell culture model was developed using the HepG2 human 
hepatoblastoma cell line with oleic acid as the model fatty acid.  Our observations on 
oleic acid-loaded HepG2 cells being less susceptible to TBHP-induced oxidative stress 
and TNF-α induced inflammation is surprising as the accumulation of fat is generally 
associated with increased susceptibility to oxidative stress (9-11).  However these results 
are in agreement with a recent study (67) that also reported that fat-loaded HepG2 
spheroids were less susceptible to oxidative challenge and inflammation.   However, it is 
also possible that the effect of fat loading depends on the type of fatty acid used. Prior 
work by Nanji et al. (7) has shown that  the severity of ALD pathology in alcohol fed 
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rats correlates to the amount of linoleic acid in the diet.  This is also supported by 
Gomez-Lechon et al. (68) who demonstrated that composition and concentration of fatty 
acid loading is important in determining fat loading toxicity.  The authors show that fat 
loading hepatocytes with 0.5 mM oleic acid for 24 hours did not significantly reduce cell 
viability, but fat loading with 1.0 mM palmitic acid reduced cell viability by 40%.  Thus, 
development of an accurate model representing fat accumulation in AS likely depends 
on fatty acid composition and concentration.  Investigating the effect of different fatty 
acids (palmitic, linoleic) as well as combinations of fatty acids is a logical next line of 
investigation.  
Based on our data showing that oxidative stress is a key determinant of protein 
expression changes in AS, we hypothesized that carbonyl modification of proteins will 
also be significant during AS and can explain the down-regulation of anti-oxidant 
enzymes such as PRDX6 and ALDH2. Carbonylation is a widely prevalent irreversible 
oxidative modification of proteins (70), and it is known that carbonylated proteins are 
susceptible to ubiquitination and subsequent degradation by proteosomal/lyosomal 
pathways (79, 80).  Our findings on less carbonylated proteins being present in oleic 
acid-loaded HepG2 cells is also in good agreement with cytotoxicity and inflammation 
assays. Our results (Figure 8) show that a majority of carbonylated proteins are found 
towards the bottom of the gel. (i.e., below 45 kilodaltons). This indicates that the 
majority of detected carbonylated proteins were fragmented, and is likely the result of 
increased degradation (as would be expected with carbonylated proteins).   
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It is not surprising that a broad spectrum of proteins (cytoskeleton, metabolism, 
fatty acid synthesis and transport) were all carbonylated, as the oxidant exposure likely 
produces an even distribution of TBHP and subjects a broad range of proteins to 
oxidative damage.  Many chaperone proteins were carbonylated (Table 2), and our data 
show reduced levels of chaperone proteins Hsc70 and Erp29.  Chaperone proteins are 
common targets of ROS attack and researchers have identified damaged or 
malfunctioning chaperone proteins as part cellular pathologies (71).  Peptidyl-prolyl cis-
trans isomerase is an abundant and ubiquitous folding protein that catalyzes the cis-trans 
isomerization of certain proline residues (72).  Chaperone proteins are involved in 
protein folding and have been reported as vulnerable to oxidative stress (70), and this 
supports the finding that mice fed ethanol intragastrically developed protein misfolding 
response and endoplasmic reticulum stress (81).  The fact that several ubuquitin related 
proteins were carbonylated suggests a reduced ability to clear damaged proteins and may 
contribute to the formation of protein aggregates associated with oxidized proteins (20, 
21, 70, 81).  Similarly, it is also possible that excessive degradation or dysfunction of 
fatty acid transport and synthesis proteins contribute to the possible toxic effects fat 
accumulation, and explains the association of increased fat accumulation with increased 
oxidative stress in alcoholic steatosis.   
Development of an in vitro fat loading hepatocyte model actually demonstrated 
that fat loading with low concentration oleic acid actually produces enhanced protection 
against oxidative stress and TNF-α induced inflammatory response.  It thus appears that 
in vitro fat-loading in order to accurately mimic fat accumulation during alcoholic 
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steatosis is a complex and multi-variate phenomenon and requires careful consideration. 
Further directions in this regard include evaluating the effect of different fatty acids, 
both individually and in combination.  
The identification of carbonylated proteins yielded interesting results and 
suggested chaperone, ubutiquin, and fatty acid transport and synthesis proteins are 
vulnerable to carbonylation during a state of oxidative stress.  Future work in this area 
will focus on determining if these carbonylated proteins are decreased in expression 
using quantitative iTRAQ mass spectrometry (82). This, coupled with multi-dimensional 
protein identification approaches such as liquid chromatography, will generate a more 
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